List of vaccines and treatments for COVID-19
All applications for vaccines and treatments for COVID-19 received by Health Canada.
| Product name | Company name | Product type | Status | Date of approval | Approved for different indication |
|---|---|---|---|---|---|
| Janssen COVID-19 Vaccine (Ad26.COV2.S [recombinant]) | Janssen Inc | Vaccine | Authorized By Interim Order | No | |
| AstraZeneca COVID-19 Vaccine (ChAdOx1-S [recombinant]) | AstraZeneca Canada Inc | Vaccine | Authorized By Interim Order | No | |
| COVISHIELD (ChAdOx1-S [recombinant]) | Verity Pharmaceuticals Inc/Serum Institute of India (in partnership with AstraZeneca Canada Inc) | Vaccine | Authorized By Interim Order | No | |
| COVID-19 Vaccine Moderna (mRNA-1273 SARS-CoV-2) | Moderna Therapeutics Inc | Vaccine | Authorized By Interim Order | No | |
| Pfizer-BioNTech COVID-19 Vaccine (tozinameran) | BioNTech Manufacturing GmbH | Vaccine | Authorized By Interim Order | No | |
| Bamlanivimab (bamlanivimab) | Eli Lilly Canada Inc | Treatment | Authorized By Interim Order | No | |
| Veklury (remdesivir) | Gilead Sciences Canada Inc | Treatment | Authorized | No | |
| Favipiravir (favipiravir) | Dr Reddys Laboratories Ltd | Treatment | Under review | Under review | |
| Colchicine (colchicine) | Pendopharm Division of Pharmascience Inc | Treatment | Under review | Under review | Yes |
| Novavax COVID-19 Vaccine (NVX-CoV2373) | Novavax Inc | Vaccine | Under review | Under review | No |
| Bamlanivimab and etesevimab (LY-CoV555 / LY-CoV016) | Eli Lilly Canada Inc | Treatment | Under review | Under review | No |
| Casirivimab and imdevimab (casirivimab / imdevimab) | Hoffmann-La Roche Limited | Treatment | Under review | Under review | No |
| Leronlimab (leronlimab) | CytoDyn, Inc. | Treatment | Under review | Under review | No |
| Sotrovimab (sotrovimab) | GlaxoSmithKline Inc | Treatment | Under review | Under review | No |